Distinct fragmentation patterns of circulating viral cell-free DNA in 83,552 non-invasive prenatal testing samples

被引:0
|
作者
Linthorst, Jasper [1 ,2 ]
Welkers, Matthijs R. A. [3 ]
Sistermans, Erik A. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC, Dept Human Genet, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Reprod & Dev Res Inst, Amsterdam UMC, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Med Microbiol & Infect Prevent, NL-1081 BT Amsterdam, Netherlands
关键词
Virome; fragmentomics; DNA degradation; epigenetics; viral cell-free DNA; NIPT; PLASMA; REVEAL;
D O I
10.20517/evcna.2021.13
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aim: The fragmentation characteristics of cell-free DNA (cfDNA) are informative biomarkers in liquid biopsies, including non-invasive prenatal testing (NIPT), as they provide insights into the origins of the cfDNA. Viral infections by DNA viruses can contribute to the available cfDNA in these samples. Here, we characterize the fragment size distribution of viral cfDNA fragments obtained from available anonymous NIPT samples. Methods: A viral database of 224 DNA viruses was generated from the NCBI RefSeq viral database. Paired-end cfDNA sequencing reads from 83.522 NIPT samples that did not map to any of the human chromosomes, or mitochondrial DNA of the human reference genome build GRCh38 (excluding alternative and unplaced contigs) were remapped to the generated viral database. Reads mapping to the 14 most abundant DNA viruses were selected, and fragment size distributions were analyzed in detail. Results: Distinct fragmentation patterns were identified for several DNA viruses, most likely due to differences in viral tropism, chromatinization (binding of nucleosomes), and the topology of the viral DNA. In high viral load parvo B19 positive samples, the fragment size distribution differed between samples, potentially reflecting the state of the infection. Conclusion: These findings outline the potential for liquid biopsies to elucidate the dynamics behind the viral infection, which may potentially have various clinical applications. Our data provide preliminary insights on the use of fragmentomics of viral cfDNA to distinguish between reactivation, reinfection, and primary infection and monitoring the state of viral infections.
引用
收藏
页码:228 / 237
页数:10
相关论文
共 50 条
  • [41] NON-INVASIVE PRENATAL SEX IDENTIFICATION USING CELL-FREE FETAL DNA IN MATERNAL CIRCULATION
    Durgud, Meriem R.
    Stoyanova, Vili K.
    Popov, Nikolay T.
    Minchev, Danail S.
    Ivanov, Hristo Y.
    Minkov, Ivan N.
    Vachev, Tihomir I.
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2018, 71 (12): : 1687 - 1693
  • [42] Non-invasive prenatal diagnosis by genome-wide haplotyping of cell-free plasma DNA
    Che, H.
    Villela, D.
    Dimitriadou, E.
    Melotte, C.
    Brison, N.
    Neofytou, M.
    Van den Bogaert, K.
    Tsuiko, O.
    Devriendt, K.
    Legius, E.
    Esteki, M. Zamani
    Voet, T.
    Vermeesch, J. R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 30 - 31
  • [43] Non-invasive prenatal test using cell free DNA
    Kim, Kunwoo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2015, 58 (11): : 995 - 1002
  • [44] DETECTION OF GLIOMA AND PROGNOSTIC SUBTYPES BY NON-INVASIVE CIRCULATING CELL-FREE DNA METHYLATION MARKERS
    Noushmehr, H.
    Sabedot, T.
    Malta, T.
    Nelson, K.
    Snyder, J.
    Wells, M.
    deCarvalho, A.
    Mukherjee, A.
    Chitale, D.
    Mosella, M.
    Asmaro, K.
    Robin, A.
    Rosenblum, M.
    Mikkelsen, T.
    Rock, J.
    Poisson, L.
    Walbert, T.
    Kalkanis, S.
    Castro, A.
    NEURO-ONCOLOGY, 2019, 21 : 6 - 6
  • [45] Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing
    Juozas Gordevičius
    Milda Narmontė
    Povilas Gibas
    Kotryna Kvederavičiūtė
    Vita Tomkutė
    Priit Paluoja
    Kaarel Krjutškov
    Andres Salumets
    Edita Kriukienė
    Clinical Epigenetics, 2020, 12
  • [46] Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing
    Gordevicius, Juozas
    Narmonte, Milda
    Gibas, Povilas
    Kvederaviciute, Kotryna
    Tomkute, Vita
    Paluoja, Priit
    Krjutskov, Kaarel
    Salumets, Andres
    Kriukiene, Edita
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [47] Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma
    Benn, Peter
    Cuckle, Howard
    PRENATAL DIAGNOSIS, 2014, 34 (08) : 778 - 783
  • [48] Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory
    Togneri, Fiona S.
    Kilby, Mark D.
    Young, Elizabeth
    Court, Samantha
    Williams, Denise
    Griffiths, Michael J.
    Allen, Stephanie K.
    GENETICS RESEARCH, 2019, 101
  • [49] Cell-free fetal DNA based non-invasive prenatal testing: a systematic review and meta-analysis of diagnostic accuracy
    Mackie, F. L.
    Morris, R. K.
    Hemming, K.
    Allen, S.
    Kilby, M. D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 2 - 3
  • [50] Non-invasive prenatal diagnosis of Down syndrome and the use of cell-free fetal DNA testing: Current knowledge and novel insights
    Sifakis, Stavros
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S83 - S83